Microcrater-Arrayed Chemiluminescence Cell Chip to Boost Anti-Cancer Drug Administration in Zebrafish Tumor Xenograft Model

Purpose: The aim of this study was to develop a rapid and automatic drug screening platform using microcrater-arrayed (µCA) cell chips. Methods: The µCA chip was fabricated using a laser direct writing technique. The fabrication time required for one 9 × 9 microarray wax chip was as quick as 1 min....

Full description

Bibliographic Details
Main Authors: Ching-Te Kuo, Yu-Sheng Lai, Siang-Rong Lu, Hsinyu Lee, Hsiu-Hao Chang
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Biology
Subjects:
Online Access:https://www.mdpi.com/2079-7737/11/1/4
_version_ 1797495749346328576
author Ching-Te Kuo
Yu-Sheng Lai
Siang-Rong Lu
Hsinyu Lee
Hsiu-Hao Chang
author_facet Ching-Te Kuo
Yu-Sheng Lai
Siang-Rong Lu
Hsinyu Lee
Hsiu-Hao Chang
author_sort Ching-Te Kuo
collection DOAJ
description Purpose: The aim of this study was to develop a rapid and automatic drug screening platform using microcrater-arrayed (µCA) cell chips. Methods: The µCA chip was fabricated using a laser direct writing technique. The fabrication time required for one 9 × 9 microarray wax chip was as quick as 1 min. On a nanodroplet handling platform, the chip was pre-coated with anti-cancer drugs, including cyclophosphamide, cisplatin, doxorubicin, oncovin, etoposide, and 5-fluorouracil, and their associated mixtures. Cell droplets containing 100 SK-N-DZ or MCF-7 cells were then loaded onto the chip. Cell viability was examined directly through a chemiluminescence assay on the chip using the CellTiter-Glo assay. Results: The time needed for the drug screening assay was demonstrated to be less than 30 s for a total of 81 tests. The prediction of optimal drug synergy from the µCA chip was found by matching it to that of the zebrafish MCF-7 tumor xenograft model, instead of the conventional 96-well plate assay. In addition, the critical reagent volume and cell number for each µCA chip test were 200 nL and 100 cells, respectively, which were significantly lower than 100 µL and 4000 cells, which were achieved using the 96-well assay. Conclusion: Our study for the µCA chip platform could improve the high-throughput drug synergy screening targeting the applications of tumor cell biology.
first_indexed 2024-03-10T01:54:04Z
format Article
id doaj.art-8576c4f28e6e46b7a57f01704fbd3a4d
institution Directory Open Access Journal
issn 2079-7737
language English
last_indexed 2024-03-10T01:54:04Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series Biology
spelling doaj.art-8576c4f28e6e46b7a57f01704fbd3a4d2023-11-23T12:59:33ZengMDPI AGBiology2079-77372021-12-01111410.3390/biology11010004Microcrater-Arrayed Chemiluminescence Cell Chip to Boost Anti-Cancer Drug Administration in Zebrafish Tumor Xenograft ModelChing-Te Kuo0Yu-Sheng Lai1Siang-Rong Lu2Hsinyu Lee3Hsiu-Hao Chang4Department of Mechanical and Electro-Mechanical Engineering, National Sun Yat-sen University, Kaohsiung 80424, TaiwanDepartment of Life Science, National Taiwan University, Taipei 10617, TaiwanDepartment of Life Science, National Taiwan University, Taipei 10617, TaiwanDepartment of Life Science, National Taiwan University, Taipei 10617, TaiwanDepartment of Pediatrics, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei 10617, TaiwanPurpose: The aim of this study was to develop a rapid and automatic drug screening platform using microcrater-arrayed (µCA) cell chips. Methods: The µCA chip was fabricated using a laser direct writing technique. The fabrication time required for one 9 × 9 microarray wax chip was as quick as 1 min. On a nanodroplet handling platform, the chip was pre-coated with anti-cancer drugs, including cyclophosphamide, cisplatin, doxorubicin, oncovin, etoposide, and 5-fluorouracil, and their associated mixtures. Cell droplets containing 100 SK-N-DZ or MCF-7 cells were then loaded onto the chip. Cell viability was examined directly through a chemiluminescence assay on the chip using the CellTiter-Glo assay. Results: The time needed for the drug screening assay was demonstrated to be less than 30 s for a total of 81 tests. The prediction of optimal drug synergy from the µCA chip was found by matching it to that of the zebrafish MCF-7 tumor xenograft model, instead of the conventional 96-well plate assay. In addition, the critical reagent volume and cell number for each µCA chip test were 200 nL and 100 cells, respectively, which were significantly lower than 100 µL and 4000 cells, which were achieved using the 96-well assay. Conclusion: Our study for the µCA chip platform could improve the high-throughput drug synergy screening targeting the applications of tumor cell biology.https://www.mdpi.com/2079-7737/11/1/4drug screeningzebrafish xenograftmicroarray chipchemiluminescence
spellingShingle Ching-Te Kuo
Yu-Sheng Lai
Siang-Rong Lu
Hsinyu Lee
Hsiu-Hao Chang
Microcrater-Arrayed Chemiluminescence Cell Chip to Boost Anti-Cancer Drug Administration in Zebrafish Tumor Xenograft Model
Biology
drug screening
zebrafish xenograft
microarray chip
chemiluminescence
title Microcrater-Arrayed Chemiluminescence Cell Chip to Boost Anti-Cancer Drug Administration in Zebrafish Tumor Xenograft Model
title_full Microcrater-Arrayed Chemiluminescence Cell Chip to Boost Anti-Cancer Drug Administration in Zebrafish Tumor Xenograft Model
title_fullStr Microcrater-Arrayed Chemiluminescence Cell Chip to Boost Anti-Cancer Drug Administration in Zebrafish Tumor Xenograft Model
title_full_unstemmed Microcrater-Arrayed Chemiluminescence Cell Chip to Boost Anti-Cancer Drug Administration in Zebrafish Tumor Xenograft Model
title_short Microcrater-Arrayed Chemiluminescence Cell Chip to Boost Anti-Cancer Drug Administration in Zebrafish Tumor Xenograft Model
title_sort microcrater arrayed chemiluminescence cell chip to boost anti cancer drug administration in zebrafish tumor xenograft model
topic drug screening
zebrafish xenograft
microarray chip
chemiluminescence
url https://www.mdpi.com/2079-7737/11/1/4
work_keys_str_mv AT chingtekuo microcraterarrayedchemiluminescencecellchiptoboostanticancerdrugadministrationinzebrafishtumorxenograftmodel
AT yushenglai microcraterarrayedchemiluminescencecellchiptoboostanticancerdrugadministrationinzebrafishtumorxenograftmodel
AT siangronglu microcraterarrayedchemiluminescencecellchiptoboostanticancerdrugadministrationinzebrafishtumorxenograftmodel
AT hsinyulee microcraterarrayedchemiluminescencecellchiptoboostanticancerdrugadministrationinzebrafishtumorxenograftmodel
AT hsiuhaochang microcraterarrayedchemiluminescencecellchiptoboostanticancerdrugadministrationinzebrafishtumorxenograftmodel